Etanercept
- PDF / 169,282 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 0 Downloads / 169 Views
1
Etanercept Injection site reaction: case report In a single centre, observational, retrospective real life study of 40 patients, who received etanercept between 21 October 2016 and 31 March 2017, a patient [age and sex not stated] was described, who developed an episode of injection site reaction during treatment with etanercept. The patient, who started receiving etanercept injection [etanercept biosimilar SB4; dosage and route not stated] following prior unspecified systemic conventional and biologic treatments. However, the patient developed an episode of injection site reaction [time to reaction onset not stated]. Therapy with etanercept was maintained. Author comment: "No serious adverse events were observed or reported. One patient experienced an episode of injection site reaction that did not require treatment interruption." Giunta A, et al. Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis: a single-centre, observational, retrospective, real-life study. British Journal of Dermatology 181: 1078-1079, No. 5, Nov 2019. Available from: 803440575 URL: http://doi.org/10.1111/bjd.18090 - Italy
0114-9954/19/1784-0001/$14.95 Adis © 2019 Springer Nature Switzerland AG. All rights reserved
Reactions 21 Dec 2019 No. 1784
Data Loading...
